Re­gen­eron joins the hunt for an­ti­bod­ies to fight a brew­ing pan­dem­ic as re­searchers whip up new tri­als for an­tivi­rals

Count Re­gen­eron as the lat­est big bio­phar­ma com­pa­ny to pitch in on find­ing a ther­a­py to com­bat the Wuhan virus.

Health and Hu­man Ser­vices said on Tues­day that they’ll be work­ing with Re­gen­eron to use its an­ti­body plat­form tech — one of the best in the world — to hunt for a ther­a­py to fight the lethal virus. This is an ex­pan­sion of a joint project they set up a lit­tle more than 2 years ago to hunt for an­ti­bod­ies that worked against Ebo­la and 9 oth­er virus­es, in­clud­ing flu virus­es.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER